Roberts Paul A, Loxham Susan J G, Poucher Simon M, Constantin-Teodosiu Dumitru, Greenhaff Paul L
School of Biomedical Sciences, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK.
J Physiol. 2002 Nov 15;545(1):297-304. doi: 10.1113/jphysiol.2002.021055.
The present study examined the effect of adrenaline infusion on the activation status of glycogen phosphorylase and the pyruvate dehydrogenase complex (PDC) and on the accumulation of glucose-6-phosphate (G-6-P) and acetylcarnitine in resting canine skeletal muscle. The study was performed in an effort to gain some insight into the temporal relationship between glycogen phosphorylase and PDC activation in vivo in skeletal muscle, which is currently unresolved. Multiple muscle samples were obtained from canine brachial muscle (n = 10) before and during (1, 3, 7 and 15 min) adrenaline infusion (0.14 microg (kg body mass)(-1) min(-1), I.V.). Adrenaline infusion increased glycogen phosphorylase "a" by > 2-fold above basal levels after 3 min (pre-infusion = 9.2 +/- 1.1 vs. 3 min = 22.3 +/- 4.0 mmol glucosyl units (kg dry muscle)(-1) min(-1), P < 0.05). The concentration of G-6-P increased transiently from its basal concentration at 1 min (pre-infusion = 1.5 +/- 0.2 vs. 1 min = 4.4 +/- 0.9 mmol kg dry muscle)(-1), P < 0.01), declined to its pre-infusion concentration at 3 min (P < 0.05), and then increased again after 7 min of infusion (P < 0.05). The PDC was activated following 7 min of adrenaline infusion (pre-infusion = 0.22 +/- 0.04 vs. 7 min = 1.04 +/- 0.15 mmol acetyl-CoA (kg wet muscle)(-1) min(-1), P < 0.01), and this degree of activation was maintained for the duration of infusion. During the first 3 min of infusion, the concentration of acetylcarnitine declined (pre-infusion = 3.8 +/- 0.3 vs. 3 min = 1.6 +/- 0.2 mmol (kg dry muscle)(-1), P < 0.05), before transiently increasing at 7 min above the 3 min concentration (3 min = 1.6 +/- 0.2 vs. 7 min = 5.1 +/- 1.0 mmol (kg dry muscle)(-1), P < 0.01). This is the first study to demonstrate that adrenaline can indirectly activate the PDC in skeletal muscle in vivo at rest. The results demonstrate that adrenaline increased glycogen phosphorylase activation and glycolytic flux within 3 min of infusion, but took several more minutes to activate the PDC. This temporal relationship, combined with a probable adrenaline-induced increase in metabolic rate (and thereby resting ATP demand), resulted in the biphasic changes in G-6-P and acetylcarnitine with infusion time.
本研究检测了肾上腺素输注对静息犬骨骼肌中糖原磷酸化酶和丙酮酸脱氢酶复合体(PDC)的激活状态,以及对葡萄糖-6-磷酸(G-6-P)和乙酰肉碱蓄积的影响。进行该研究旨在深入了解骨骼肌中糖原磷酸化酶和PDC在体内激活的时间关系,目前这一关系尚未明确。在肾上腺素输注(静脉注射,0.14μg(kg体重)⁻¹min⁻¹)前及输注期间(1、3、7和15分钟),从犬肱二头肌获取多个肌肉样本(n = 10)。输注肾上腺素3分钟后,糖原磷酸化酶“a”增加至基础水平的2倍以上(输注前 = 9.2±1.1 vs. 3分钟 = 22.3±4.0 mmol葡萄糖基单位(kg干肌肉)⁻¹min⁻¹,P < 0.05)。G-6-P浓度在1分钟时从基础浓度短暂升高(输注前 = 1.5±0.2 vs. 1分钟 = 4.4±0.9 mmol kg干肌肉⁻¹,P < 0.01),在3分钟时降至输注前浓度(P < 0.05),然后在输注7分钟后再次升高(P < 0.05)。输注肾上腺素7分钟后PDC被激活(输注前 = 0.22±0.04 vs. 7分钟 = 1.04±0.15 mmol乙酰辅酶A(kg湿肌肉)⁻¹min⁻¹,P < 0.01),且这种激活程度在输注期间持续保持。在输注的前3分钟,乙酰肉碱浓度下降(输注前 = 3.8±0.3 vs. 3分钟 = 1.6±0.2 mmol(kg干肌肉)⁻¹,P < 0.05),然后在7分钟时短暂升高至高于3分钟时的浓度(3分钟 = 1.6±0.2 vs. 7分钟 = 5.1±1.0 mmol(kg干肌肉)⁻¹,P < 0.01)。这是第一项证明肾上腺素可在体内静息状态下间接激活骨骼肌中PDC的研究。结果表明,输注肾上腺素3分钟内可增加糖原磷酸化酶的激活和糖酵解通量,但需要再过几分钟才能激活PDC。这种时间关系,再加上肾上腺素可能引起的代谢率增加(从而导致静息ATP需求增加),导致G-6-P和乙酰肉碱浓度随输注时间出现双相变化。